Viper venom disintegrins and related molecules

Proceedings of the Society for Experimental Biology and Medicine

Volumn 219, Issue 2, 1998, Pages 109-119

  McLane, Mary Ann ^a   Marcinkiewicz, Cezary ^b   Vijay Kumar, Senadhi ^b   Wierzbicka Patynowski, Iwona ^b   Niewiarowski, Stefan ^b  

^a UNIVERSITY OF DELAWARE   (United States)

^b TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBOLABRIN; BARBOURIN; BITISTATIN; DENDROASPIN; DISINTEGRIN; ECHISTATIN; EPTIFIBATIDE; ERISTOSTATIN; FIBRINOGEN RECEPTOR ANTAGONIST; FLAVORIDIN; KISTRIN; TRIFLAVIN; UNCLASSIFIED DRUG; VIPER VENOM;

AMINO ACID SEQUENCE; ANIMAL CELL; CANCER INHIBITION; CONFERENCE PAPER; GENE MUTATION; HUMAN; HUMAN CELL; NONHUMAN; PROTEIN ANALYSIS; PROTEIN EXPRESSION; SEQUENCE HOMOLOGY; THROMBOSIS PREVENTION; TOXIN ANALYSIS;

ANIMALIA; SERPENTES; VERTEBRATA; VIPER;

EID: 0031695498     PISSN: 00379727     EISSN: None     Source Type: Journal    
DOI: 10.3181/00379727-219-44322     Document Type: Conference Paper

References (103)

1. Fujimura Y, Kawasaki T, Titani K. Snake venom proteins modulating the interaction between von Willebrand factor and platelet glycoprotein Ib. Thromb Haemost 76:633-639, 1996.
2. Bjarnason JB, Fox JW. Hemorrhagic metalloproteinases from snake venoms. Pharmacol Ther 62:325-372, 1994.
3. Hite LA, Jia LG, Bjarnason JB, Fox JW. cDNA sequences for four snake venom metalloproteinases: Structure, classification, and their relationship to mammalian reproductive proteins. Arch Biochem Biophys 308:182-191, 1994.
4. Wolfsberg TG, White JM. ADAMs in fertilization and development. Dev Biol 180:389-401, 1996.
5. Blobel CP. Metalloprotease-disintegrins: Links to cell adhesion and cleavage of TNF alpha and Notch. Cell 90:589-592, 1997.
6. Hite LA, Fox JW, Bjarnason JB. A new family of proteinases is defined by several snake venom metalloproteinases. Biol Chem Hoppe Seyler 373:381-385, 1992.
7. Takeya H, Oda K, Miyata T, Omori Satoh T, Iwanaga S. The complete amino acid sequence of the high molecular mass hemorrhagic protein HR 1B isolated from the venom of Trimeresimis flavoviridis. J Biol Chem 265:16068-16073, 1990.
8. Perry AC, Jones R, Barker PJ, Hall L. A mammalian epididymal protein with remarkable sequence similarity to snake venom haemorrhagic peptides. Biochem J 286:671-675.
9. Paine MJ, Desmond HP, Theakston RD, Crampton JM. Purification, cloning, and molecular characterization of a high molecular weight hemorrhagic metalloprotease, jararhagin, from Bothrops jararaca venom: Insights into the disintegrin gene family. J Biol Chem 267:22869-22876, 1992.
10. Takeya H, Nishida S, Miyata T, Kawada S, Saisaka Y, Monta T, Iwanaga S. Coagulation factor X activating enzyme from Russell's viper venom (RVV-X): A novel metalloproteinase with disintegrin (platelet aggregation inhibitor)-like and C-type lectin-like domains. J Biol Chem 267:14109-14117, 1992.
11. Blobel CP, Wolfsberg TG, Turck CW, Myles DG, Primakoff P, White JM. A potential fusion peptide and an integrin domain in a protein active in sperm-egg fusion [see comments]. Nature 356:248-252, 1992.
12. Heinlein UA, Wallat S, Senftleben A, Lemaire L. Male germ cell expressed mouse gene TAZ83 encodes a putative, cysteine-rich transmembrane protein (cyritestin) sharing homologies with snake toxins and sperm-egg fusion proteins. Dev Growth Differ 36:49-58, 1994.
13. Shebuski RJ, Ramjit DR, Bencen GH, Polokoff MA. Characterization and platelet inhibitory activity of bitistatin, a potent arginine-glycine-aspartic acid-containing platelet from the venom of the viper Bitis arietans. J. Biol Chem 264:21550-21556, 1989.
14. Huang TF, Holt JC, Kirby EP, Niewiarowski S. Trigramin: Primary structure and its inhibition of von Willebrand factor binding to glycoprotein IIb/IIIa complex on human platelets. Biochemistry 28:661-666, 1989.
15. Dennis MS, Henzel WJ, Pitti RM, Lipari MT, Napier MA, Deisher TA, Bunting S, Lazarus RA. Platelet glycoprotein Ub-IIIa protein antagonists from snake venoms: Evidence for a family of platelet-aggregation inhibitors. Proc Natl Acad Sci USA 87:2471-2475, 1990.
16. Scarborough RM, Rose JW, Hsu MA, Phillips DR, Fried VA, Campbell AM, Nannizzi L, Charo IF. Barbourin: A GPIIb-IIa-specific integrin antagonist from the venom of Sistrurus m. barbouri. J Biol Chem 266:9359-9362, 1991.
17. Gan ZR, Gould RJ, Jacobs JW, Friedman PA, Polokoff MA. Echistatin: A potent platelet aggregation inhibitor from the venom of the viper, echis cannants. J Biol Chem 263:19827-19832, 1988.
18. Huang TF, Holt JC, Lukasiewicz H, Niewiarowski S. Trigramin: A low-molecular-weight peptide inhibiting fibrinogen interaction with platelet receptors expressed on glycoprotein IIb-IIIa complex. J Biol Chem 262:16157-16163, 1987.
19. Gould RJ, Polokoff MA, Friedman PA, Huang TF, Holt JC, Cook JJ, Niewiarowski S. Disintegrins: A family of integrin inhibitory proteins from viper venoms. Proc Soc Exp Biol Med 195:168-171, 1990.
20. Niewiarowski S, McLane MA, Kloczewiak M, Stewart GJ. Disintegrins and other naturally occurring antagonists of platelet fibrinogen receptors. Semin Hematol 31:289-300, 1994.
21. Au LC, Huang YB, Huang TF, Teh GW, Lin HH, Choo KB. A common precursor for a putative hemorrhagic protein and rhodostomin, a platelet aggregation inhibitor of the venom of Calloselasma rhodostoma: Molecular cloning and sequence analysis. Biochem Biophys Res Commun 181:585-593, 1991.
22. Trikha M, De Clerck YA, Markland FS. Contortrostatin, a snake venom disintegrin, inhibits β1 integrin-mediated human metastatic melanoma cell adhesion and blocks experimental metastasis. Cancer Res 54:4993-4998, 1994.
23. Clark EA, Trikha M, Markland FS, Brugge JS. Structurally distinct disintegrins Contortrostatin and multisquamatin differentially regulate platelet tyrosine phosphorylation. J Biol Chem 269:21940-21943, 1994.
24. Marcinkiewicz C, Calvete JJ, Niewiarowski S. Isolation and characterization of two novel dimeric disintegrins: EC-3 and EMF-10 inhibiting interaction of lymphoid cells with VCAM-1. (abstract 2966) Blood 90:59b, 1997.
25. Marcinkiewicz C, Calvete JJ, Marcinkiewicz M, Raida M, Lobb RR, Niewiarowski S. EC-3, a novel MLD-dependent disintegrin from E. carniatus, is a potent antagonist of α4 integrins. J Cell Biol 8:290a, 1998.
26. Calvete JJ, Schrader M, Raida M, McLane MA, Romero A, Niewiarowski S. The disulphide bond pattern of bitistatin, a disintegrin isolated from the venom of the viper Bitis arietans. FEBS Lett 416:197-202, 1997.
27. Saudek V, Atkinson RA, Pelton JT. Three-dimensional structure of echistatin, the smallest active RGD protein. Biochemistry 30:7369-7372, 1991.
28. Adler M, Lazarus RA, Dennis MS, Wagner G. Solution structure of kistrin, a potent platelet aggregation inhibitor and GP IIb-IIIa antagonist. Science 253:445-448, 1991.
29. Senn H, Klaus W. The nuclear magnetic resonance solution structure of flavoridin, an antagonist of the platelet GP IIb-IIIa receptor. J Mol Biol 232:907-925, 1993.
30. Smith KJ, Jaseja M, Lu X, Williams JA, Hyde EI, Trayer IP. Three-dimensional structure of the RGD-containing snake toxin albolabrin in solution, based on 1H NMR spectroscopy and simulated annealing calculations. Int J Pept Protein Res 48:220-228, 1996.
31. Garsky VM, Lumma PK, Freidinger RM, Pitzenberger SM, Randall WC, Veber DF, Gould RJ, Friedman PA. Chemical synthesis of echistatin, a potent inhibitor of platelet aggregation from Echis carinatus: Synthesis and biological activity of selected analogs. Proc Natl Acad USA 86:4022-4026, 1989.
32. Dennis MS, Carter P, Lazarus RA. Binding interactions of kistrin with platelet glycoprotein IIb-IIIa: Analysis by site-directed mutagenesis. Proteins 15:312-321, 1993.
33. Calvete JJ, Schäfer W, Soszka T, Lu WQ, Cook JJ, Jameson BA, Niewiarowski S. Identification of the disulfide bond pattern in albolabrin, an RGD-containing peptide from the venom of Trimeresurus albolabris: Significance for the expression of platelet aggregation inhibitory activity. Biochemistry 30:5225-5229, 1991.
34. Saudek V, Atkinson RA, Lepage P, Pelton JT. The secondary structure of echistatin from 1H-NMR, circular-dichroism and Raman spectroscopy. Eur J Biochem 202:329-338, 1991.
35. Calvete JJ, Wang Y, Mann K, Schäfer W, Niewiarowski S, Stewart GJ. The disulfide bridge pattern of snake venom disintegrins, flavoridin and echistatin. FEBS Lett 309:316-320, 1992.
36. McLane MA, Vijay Kumar S, Marcinkiewicz C, Calvete JJ, Niewiarowski S. Importance of the structure of the RGD-containing loop in the disintegrins echistatin and eristostatin for recognition of alphaIIbbeta3 and alphavbeta3 integrins. FEBS Lett 391:139-143, 1996.
37. McDowell RS, Dennis MS, Loui A, Shuster M, Mulkerrin MG, Lazarus RA. Mambin, a potent glycoprotein IIb-IIIa antagonist and platelet aggregation inhibitor structurally related to the short neurotoxins. Biochemistry 31:4766-4772, 1992.
38. Mazur P, Henzel WJ, Seymour JL, Lazarus RA. Ornatins: Potent glycoprotein IIb-IIIa antagonists and platelet aggregation inhibitors from the leech Placobdella omata. Eur J Biochem 202:1073-1082, 1991.
39. Seymour JL, Henzel WJ, Nevins B, Stults JT, Lazarus RA. Decorsin: A potent glycoprotein IIb-IIIa antagonist and platelet aggregation inhibitor from the leech Macrobdella decora. J Biol Chem 265:10143-10147, 1990.
40. Scarborough RM, Naughton MA, Teng W, Rose JW, Phillips DR, Nannizzi L, Arfsten A, Campbell AM, Charo IF. Design of potent and specific integrin antagonists: Peptide antagonists with high specificity for glycoprotein IIb-IIIa. J Biol Chem 268:1066-1073, 1993.
41. Tcheng JE, Harrington RA, Kottke MK, Kleinman NS, Ellis SG, Kereiakes DJ, Mick MJ, Navetta FI, Smith JE, Worley SJ, Miller JA, Joseph DM, Sigmon KN, Kitt MM, du Mée CP, Califf RM, Topol EJ. Multicenter, randomized, double-blind, placebo-controlled trial of the platelet integrin glycoprotein IIb/IIIa blocker Integrelin in elective coronary intervention. Circulation 91:2151-2157, 1995.
42. Knudsen KA, Tuszynski GP, Huang TF, Niewiarowski S. Trigramin, an RGD-containing peptide from snake venom, inhibits cell-substratum adhesion of human melanoma cells. Exp Cell Res 179:42-49, 1988.
43. Musial J, Niewiarowski S, Rucinski B, Stewart GJ, Cook JJ, Williams JA, Edmunds LH, Jr. Inhibition of platelet adhesion to surfaces of extracorporeal circuits by disintegrins: RGD-containing peptides from viper venoms. Circulation 82:261-273, 1990.
44. Soszka T, Knudsen KA, Beviglia L, Rossi C, Poggi A, Niewiarowski S. Inhibition of murine melanoma cell-matrix adhesion and experimental metastasis by albolabrin, an RGD-containing peptide isolated from the venom of Trimeresums albolabris. Exp Cell Res 196:6-12, 1991.
45. Beviglia L, Stewart GJ, Niewiarowski S. Effect of four disintegrins on the adhesive and metastatic properties of B16F10 melanoma cells in a murine model. Oncol Res 7:7-20, 1995.
46. Pfaff M, McLane MA, Beviglia L, Niewiarowski S, Timpl R. Comparison of disintegrins with limited variation in the RGD loop in their binding to purified integrins alphaIIbbeta3, alphavbeta3 and alpha5betal and in cell adhesion inhibition. Cell Adhes Commun 2:491-501, 1994.
47. Juliano D, Wang Y, Marcinkiewicz C, Rosenthal LA, Stewart GJ, Niewiarowski S. Disintegrin interaction with alphavbeta3 integrin on human umbilical vein endothelial cells: Expression of ligand-induced binding site on β3 subunit. Exp Cell Res 225:132-142, 1996.
48. Jones JI, Prevette T, Gockerman A, Clemmons DR. Ligand occupancy of the alphavbeta3 integrin is necessary for smooth muscle cells to migrate in response to insulin-like growth factor. Proc Natl Acad Sci USA 93:2482-2487, 1996.
49. Ruoslahti E. RGD and other recognition sequences for integrins. Annu Rev Cell Dev Biol 12:697-715, 1996.
50. Cardarelli PM, Cobb RR, Nowlin DM, Scholz W, Gorcsan F, Moscinski M, Yasuhara M, Chiang SL, Lobl TJ. Cyclic RGD peptide inhibits alpha4beta1 interaction with connecting segment 1 and vascular cell adhesion molecule. J Biol Chem 269:18668-18673, 1994.
51. Chandra-Kumar C, Huiming-Nie, Rogers CP, Malkowski M, Maxwell E, Catino JJ, Armstrong L. Biochemical characterization of the binding of echistatin to integrin αvβ3 receptor. J Pharmacol Exp Ther 283:843-853, 1998.
52. McLane MA, Kowalska MA, Silver L, Shattil SJ, Niewiarowski S. Interaction of disintegrins with the alphaIIbbeta3 receptor on resting and activated human platelets. Biochem J 301:429-436, 1994.
53. Morris VL, Schmidt EE, Koop S, Macdonald IC, Grattan M, Khokha R, McLane MA, Niewiarowski S, Chambers AF, Groom AC. Effects of the disintegrin eristostatin on individual steps of hematogenous metastasis. Exp Cell Res 219:571-578, 1995.
54. Marcinkiewicz C, Vijay Kumar S, McLane MA, Niewiarowski S. Significance of RGD loop and C-terminal domain of echistatin for recognition of alphaIIb beta3 and alpha(v) beta3 integrins and expression of ligand-induced binding site. Blood 90:1565-1575, 1997.
55. Marcinkiewicz C, Rosenthal LA, Mosser DM, Kunicki TJ, Niewiarowski S. Immunological characterization of eristostatin and echistatin binding sites on alpha IIb beta 3 and alpha V beta 3 integrins. Biochem J 317:817-825, 1996.
56. Brunger AT, Krukowski A, Erickson JW. Slow-cooling protocols for crystallographic refinement by simulated annealing. Acta Crystallogr A 46:585-593, 1990.
57. McLane MA, Marcinkiewicz C, Wierzbicka I, Hong J, Vijay Kumar S, Niewiarowski S. Effect of a double mutation in the RGD loop of the disintegrin echistatin on its interaction with αIIbβ3 and αvβ3 integrins. Blood 88:59, 1996.
58. Yamada T, Kidera A. Tailoring echistatin to possess higher affinity for integrin alpha(IIb)beta(3). FEBS Lett 387:11-15, 1996.
59. Wright PS, Saudek V, Owen TJ, Harbeson SL, Bitonti AJ. An echistatin C-terminal peptide activates GPIIbIIIa binding to fibrinogen, fibronectin, vitronectin and collagen type I and type IV. Biochem J 293:263-267, 1993.
60. McLane MA, Wierzbicka-Patynowski I, Niewiarowski S, Marcinkiewicz C, Senadi VK. Both the sequence and C-terminus of disintegrins are essential for their full potency in interactions with αIIbβ3 and αvβ3. Mol Biol Cell 8:290a, 1997.
61. Lu X, Rahman S, Kakkar VV, Authi KS. Substitutions of proline 42 to alanine and methionine 46 to asparagine around the RGD domain of the neurotoxin dendroaspin alter its preferential antagonism to that resembling the disintegrin elegantin. J Biol Chem 271:289-294, 1996.
62. Lu X, Williams JA, Deadman JJ, Salmon GP, Kakkar VV, Wilkinson JM, Baruch D, Authi KS, Rahman S. Preferential antagonism of the interactions of the integrin alpha lib beta 3 with immobilized glycoprotein ligands by snake-venom RGD (Arg-Gly-Asp) proteins: Evidence supporting a functional role for the amino acid residues flanking the tripeptide RGD in determining the inhibitory properties of snake-venom RGD proteins. Biochem J 304:929-936, 1994.
63. Rahman S, Lu X, Kakkar VV, Authi KS. The integrin alpha IIb beta 3 contains distinct and interacting binding sites for snake-venom RGD (Arg-Gly-Asp) proteins: Evidence that the receptor-binding characteristics of snake-venom RGD proteins are related to the amino acid environment flanking the sequence RGD. Biochem J 312:223-232, 1995.
64. Tselepis VH, Green LJ, Humphries MJ. An RGD to LDV motif conversion within the disintegrin kistrin generates an integrin antagonist that retains potency but exhibits altered receptor specificity: Evidence for a functional equivalence of acidic integrin-binding motifs. J Biol Chem 272:21341-21348, 1997.
65. Scarborough RM, Rose JW, Naughton MA, Phillips DR, Nannizzi L, Arfsten A, Campbell AM, Charo IF. Characterization of the integrin specificities of disintegrins isolated from American pit viper venoms. J Biol Chem 268:1058-1065, 1993.
66. Scaloni A, Di Martino E, Miraglia N, Pelagalli A, Della Morte R, Staiano N, Pucci P. Amino acid sequence and molecular modelling of glycoprotein IIb- IIa and fibronectin receptor iso-antagonists from Trimeresurus elegans venom. Biochem J 319:775-782, 1996.
67. Williams JA, Lu X, Rahman S, Keating C, Kakkar V. Dendroaspin: A potent integrin receptor inhibitor from the venoms of Dendroaspis viridis and D. jamesonii. Biochem Soc Trans 21:735, 1993.
68. Siddiqi AR, Persson B, Zaidi ZH, Jornvall H. Characterization of two platelet aggregation inhibitor-like polypeptides from viper venom. Peptides 13:1033-1037, 1992.
69. Yang CH, Huang TF, Liu KR, Chen MS, Hung PT. Inhibition of retinal pigment epithelial cell-induced fractional retinal detachment by distintegrins, a group of Arg-Gly-Asp-containing peptides from viper venom. Invest Ophthalmol Vis Sci 37:843-854, 1996.
70. Tsai TJ, Sheu JR, Chen YM, Yen CJ, Chen CF, Huang TF. Disintegrin modulates rat glomerular mesangial cell behavior. Nephron 70:83-90, 1995.
71. Sheu JR, Yen MH, Hung WC, Lee YM, Su CH, Huang TF. Triflavin inhibits platelet-induced vasoconstriction in de-endothelialized aorta. Arterioscler Thromb Vasc Biol 17:3461-3468, 1997.
72. Denis C, Williams JA, Lu X, Meyer D, Baruch D. Solid-phase von Willebrand factor contains a conformationally active RGD motif that mediates endothelial cell adhesion through the alpha v beta 3 receptor. Blood 82:3622-3630, 1993.
73. Wesolowski G, Duong LT, Lakkakorpi PT, Nagy RM, Tezuka K, Tanaka H, Rodan GA, Rodan SB. Isolation and characterization of highly enriched, prefusion mouse osteoclastic cells. Exp Cell Res 219:679-686, 1995.
74. Fisher JE, Caulfield MP, Sato M, Quartuccio HA, Gould RJ, Garsky VM, Rodan GA, Rosenblatt M. Inhibition of osteoclastic bone resorption in vivo by echistatin, an "arginyl-glycyl-aspartyl" (RGD)-containing protein. Endocrinology 132:1411-1413, 1993.
75. Price JT, Bonovich MT, Kohn EC. The biochemistry of cancer dissemination. Crit Rev Biochem Mol Biol 32:175-253, 1997.
76. Varner JA, Cheresh DA. Tumor angiogenesis and the role of vascular cell integrin alphavbeta3. In: DeVita VT, Hellman S, Rosenberg SA, Eds. Important Advances in Oncology. Philadelphia: JB Lippincott, pp69-87, 1996.
77. Dänen EH, Van MG, Ruiter DJ: Role of integrins as signal transducing cell adhesion molecules in human cutaneous melanoma. Cancer Surv 24:43-65, 1995.
78. Sheu JR, Lin CH, Huang TF. Triflavin, an antiplatelet peptide, inhibits tumor cell-extracellular matrix adhesion through an arginine-glycine-aspartic acid-dependent mechanism. J Lab Clin Med 123:256-263, 1994.
79. Chiang HS, Yang RS, Huang TF. The Arg-Gly-Asp-containing peptide, rodostomin, inhibits in vitro cell adhesion to extracellular matrices and platelet aggregation caused by saos-2 human osteosarcoma cells. Br J Cancer 71:265-270, 1995.
80. Staiano N, Garbi C, Squillacioti C, Esposito S, Di Martino E, Belisario MA, Nitsch L, Di Natale P. Echistatin induces decrease of pp125FAK phosphorylation, disassembly of actin cytoskeleton and focal adhesions, and detachment of fibronectin-adherent melanoma cells. Eur J Cell Biol 73:298-305, 1997.
81. Danen EHJ, Marcinkiewicz C, Cornelissen IMHA, van Kraats A, Pachter JA, Ruiter DJ, Niewiarowski S, van Muijen G.N.P. The disintegrin eristostatin interferes with integrin α4β1 function and with experimental metastasis of human melanoma cells. Exp Cell Res 238:188-196, 1998.
82. Lang SH, Clarke NW, George NJ, Testa NG. Primary prostatic epithelial cell binding to human bone marrow stroma and the role of alpha2beta1 integrin. Clin Exp Metastasis 15:218-227, 1997.
83. Jia LG, Wang XM, Shannon JD, Bjamason JB, Fox JW. Function of disintegrin-like/cysteine-rich domains of atrolysin A. Inhibition of platelet aggregation by recombinant protein and peptide antagonists. J Biol Chem 272:13094-13102, 1997.
84. Zhou Q, Dangelmaier C, Smith JB. The hemorrhagin catrocollastatin inhibits collagen-induced platelet aggregation by binding to collagen via its disintegrin-like domain. Biochem Biophys Res Commun 219:720-726, 1996.
85. Shimokawa K, Shannon JD, Jia LG, Fox JW. Sequence and biological activity of catrocollastatin-C: A disintegrin-like/cysteine-rich two-domain protein from Crotalus atrox venom. Arch Biochem Biophys 343:35-43, 1997.
86. Kini RM. Do we know the complete sequence of metalloproteinase and nonenzymatic platelet aggregation inhibitor (disintegrin) precursor proteins? Toxicon 33:1151-1160, 1995.
87. Kini RM, Evans HJ. Structural domains in venom proteins: Evidence that metalloproteinases and nonenzymatic platelet aggregation inhibitors (disintegrins) from snake venoms are derived by proteolysis from a common precursor. Toxicon 30:265-293, 1992.
88. Kamiguti AS, Hay CR, Zuzel M. Inhibition of collagen-induced platelet aggregation as the result of cleavage of alpha 2 beta 1-intergrin by the snake venom metalloproteinase jararhagin. Biochem J 320:635-641, 1996.
89. Weskamp G, Kratzschmar J, Reid MS, Blobel CP. MDC9, a widely expressed cellular disintegrin containing cytoplasmic SH3 ligand domains. J Cell Biol 132:717-726, 1996.
90. Wolfsberg TG, Bazan JF, Blobel CP, Myles DG, Primakoff P, White JM. The precursor region of a protein active in sperm-egg fusion contains a metalloprotease and a disintegrin domain: Structural, functional, and evolutionary implications. Proc Natl Acad Sci USA 90:10783-10787, 1993.
91. Almeida EA, Huovila AP, Sutherland AE, Stephens LE, Calarco PG, Shaw LM, Mercurio AM, Sonnonberg A, Primakoff P, Myles DG, White JM. Mouse egg integrin alpha 6 beta 1 functions as a sperm receptor. Cell 81:1095-1104, 1995.
92. Yuan R, Primakoff P, Myles DG. A role for the disintegrin domain of cyritestin, a sperm surface protein belonging to the ADAM family, in mouse sperm-egg plasma membrane adhesion and fusion. J Cell Biol 137:105-112, 1997.
93. Bronson RA, Gailit J, Bronson S, Oula L. Echistatin, a disintegrin, inhibits sperm-oolemmal adhesion but not oocyte penetration. Fertil Steril 64:414-420, 1995.
94. Black RA, Rauch CT, Kozlosky CJ, Peschon JJ, Slack JL, Wolfson MF, Castner BJ, Stocking KL, Reddy P, Srinivasan S, Nelson N, Boiani N, Schooley KA, Gerhart M, Davis R, Fitzner JN, Johnson RS, Paxton RJ, March CJ, Cerretti DP. A metalloproteinase disintegrin that releases tumour-necrosis factor-alpha from cells. Nature 385:729-733, 1997.
95. Moss ML, Jin SL, Milla ME, Burkhart W, Carter HL, Chen WJ, Clay WC, Didsbury JR, Hassler D, Hoffman CR, Kost TA, Lambert MH, Leesnitzer MA, McCauley P, McGeehan G, Mitchell J, Moyer M, Pahel G, Rocque W, Overton LK, Schoenen F, Seaton T, Su JL, Warner J, Becherer JD. Cloning of a disintegrin metalloproteinase that processes precursor tumour-necrosis factor-alpha. Nature 385:733-736, 1997.
96. Yagami Hiromasa T, Sato T, Kurisaki T, Karnijo K, Nabeshima Y, Fujisawa Sehara A. A metalloprotease-disintegrin participating in myoblast fusion [see comments]. Nature 377:652-656, 1995.
97. Emi M, Katagiri T, Harada Y, Saito H, Inazawa J, Ito I, Kasumi F, Nakamura Y. A novel metalloprotease/disintegrin-like gene at 17q21.3 is somatically rearranged in two primary breast cancers. Nat Genet 5:151-157, 1993.
98. Wu E, Croucher PI, McKie N. Expression of members of the novel membrane linked metalloproteinase family ADAM in cells derived from a range of haematological malignancies. Biochem Biophys Res Commun 235:437-442, 1997.
99. Herren B, Raines EW, Ross R. Expression of a disintegrin-like protein in cultured human vascular cells and in vivo. FASEB J 11:173-180, 1997.
100. Kratzschmar J, Lum L, Blobel CP. Metargidin, a membrane-anchored metalloprotease-disintegrin protein with an RGD integrin binding sequence. J Biol Chem 271:4593-4596, 1996.
101. 3 J Biol Chem 273:7345-7350, 1998.
102. Kieliszewski MJ, Showalter AM, Leykam JF. Potato lectin: A modular protein sharing sequence similarities with the extensin family, the hevein lectin family, and snake venom disintegrins (platelet aggregation inhibitors). Plant J 5:849-861, 1994.
103. Blumberg DD, Varney T, Parrish S, Casademunt E, Dolman J. A protein containing disintegrin and ornatin like domains modulates cell adhesion and cell type proportioning in Dictyostelium. Mol Biol Cell 8:6a, 1997.